[ATRA] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[ATRA] Atara Biotherapeutics, Inc.
Announcement Date
07-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 3.27%
YoY- -23.19%
Quarter Report
ATRA's Result
ATRA's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 4,459 5,370 0 0 0 0 0 -
PBT -84,081 -84,664 -74,342 -71,895 -58,361 -31,096 -25,366 22.09%
Tax 10 -541 6 0 0 0 7 6.12%
NP -840,910 -846,640 -743,480 -718,950 -583,610 -310,960 -253,730 22.09%
Tax Rate - - - - - - - -
Total Cost 845,369 852,010 743,480 718,950 583,610 310,960 253,730 22.20%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -18,858.71 -1,576.61 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -20.53 -22.61 -22.90 -32.73 -32.13 -25.51 -22.02 -1.16%
EPS Diluted -20.53 -22.61 -22.90 -32.73 -32.13 -25.51 -22.02 -1.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.